Scientists have developed a gel-based carrier that delivers a drug exclusively to the liver of obese mice and reverses their diet-induced disease.
Previous studies have shown that thyromimetics – or drugs mimicking the body’s natural thyroid hormone – are a potential way to tackle obesity, which affects over 100 million people worldwide, and other metabolic conditions like Type 2 diabetes.
